The year in epidemiology, health services, and outcomes research

Journal of the American College of Cardiology

Volumn 46, Issue 7, 2005, Pages 1362-1370

  Krumholz, Harlan M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ATORVASTATIN; CELECOXIB; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; EPLERENONE; FIBRIC ACID DERIVATIVE; FIBRINOLYTIC AGENT; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; METFORMIN; NESIRITIDE; PARECOXIB; PRAVASTATIN; ROFECOXIB; SIMVASTATIN; SPIRONOLACTONE; VALDECOXIB;

ACUTE HEART INFARCTION; ADENOMATOUS POLYP; ANGINA PECTORIS; BLEEDING; CANCER; CARDIOVASCULAR DISEASE; CARDIOVERSION; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; HEALTH CARE COST; HEALTH SERVICE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART FAILURE; HEART PACING; HUMAN; KIDNEY DISEASE; MEDICARE; OUTCOMES RESEARCH; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; RESUSCITATION; REVIEW; RHABDOMYOLYSIS; SAFETY; SIDE EFFECT; SUDDEN DEATH; THROMBOCYTOPENIA; THROMBOSIS; UNSTABLE ANGINA PECTORIS;

BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; HUMANS; SAFETY; TREATMENT OUTCOME;

EID: 27744574727     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.06.060     Document Type: Review

References (79)

1. D.J. Graham, D. Campen, R. Hui Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs nested case-control study Lancet 365 2005 475 481
2. P. Juni, L. Nartey, S. Reichenbach, R. Sterchi, P.A. Dieppe, M. Egger Risk of cardiovascular events and rofecoxib cumulative meta-analysis Lancet 364 2004 2021 2029
3. R.S. Bresalier, R.S. Sandler, H. Quan Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial N Engl J Med 352 2005 1092 1102
4. N.A. Nussmeier, A.A. Whelton, M.T. Brown Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery N Engl J Med 352 2005 1081 1091
5. S.D. Solomon, J.J. McMurray, M.A. Pfeffer Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention N Engl J Med 352 2005 1071 1080
6. D.J. Graham, J.A. Staffa, D. Shatin Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs JAMA 292 2004 2585 2590
7. T.E. Strandberg, K. Pyorala, T.J. Cook Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S) Lancet 364 2004 771 777
8. Scandinavian Simvastatin Survival Study Group Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
9. J.D. Sackner-Bernstein, H.A. Skopicki, K.D. Aaronson Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure Circulation 111 2005 1487 1491
10. J.D. Sackner-Bernstein, M. Kowalski, M. Fox, K. Aaronson Short-term risk of death after treatment with nesiritide for decompensated heart failure a pooled analysis of randomized controlled trials JAMA 293 2005 1900 1905
11. United States Food and Drug Administration. http://www.fda.gov/cder/foi/ label/2005/020920s008lbl.pdf. Accessed June 3, 2005
12. D.N. Juurlink, M.M. Mamdani, D.S. Lee Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study N Engl J Med 351 2004 543 551
13. B. Pitt, F. Zannad, W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 1999 709 717
14. F.A. Masoudi, Y. Wang, S.E. Inzucchi Metformin and thiazolidinedione use in Medicare patients with heart failure JAMA 290 2003 81 85
15. F.A. Masoudi, S.E. Inzucchi, Y. Wang, E.P. Havranek, J.M. Foody, H.M. Krumholz Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure an observational study Circulation 111 2005 583 590
16. R. Koppel, J.P. Metlay, A. Cohen Role of computerized physician order entry systems in facilitating medication errors JAMA 293 2005 1197 1203
17. F.A. Masoudi, S.S. Rathore, Y. Wang National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction Circulation 110 2004 724 731
18. J. Butler, P.G. Arbogast, J. Daugherty, M.K. Jain, W.A. Ray, M.R. Griffin Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge J Am Coll Cardiol 43 2004 2036 2043
19. S.C. Smith Jr, J.T. Dove, A.K. Jacobs ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines) - executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty) J Am Coll Cardiol 37 2001 2215 2239
20. A.J. Epstein, S.S. Rathore, K.G. Volpp, H.M. Krumholz Hospital percutaneous coronary intervention volume and patient mortality, 1998 to 2000 does the evidence support current procedure volume minimums? J Am Coll Cardiol 43 2004 1755 1762
21. C. Wu, E.L. Hannan, T.J. Ryan Is the impact of hospital and surgeon volumes on the in-hospital mortality rate for coronary artery bypass graft surgery limited to patients at high risk? Circulation 110 2004 784 789
22. D.E. Wennberg, F.L. Lucas, A.E. Siewers, M.A. Kellett, D.J. Malenka Outcomes of percutaneous coronary interventions performed at centers without and with onsite coronary artery bypass graft surgery JAMA 292 2004 1961 1968
23. T.P. Wharton Jr, L.L. Grines, M.A. Turco Primary angioplasty in acute myocardial infarction at hospitals with no surgery on-site (the PAMI-No SOS study) versus transfer to surgical centers for primary angioplasty J Am Coll Cardiol 43 2004 1943 1950
24. E.H. Bradley, J. Herrin, J.A. Mattera Quality improvement efforts and hospital performance rates of beta-blocker prescription after acute myocardial infarction Med Care 43 2005 282 292
25. N. Kucher, S. Koo, R. Quiroz Electronic alerts to prevent venous thromboembolism among hospitalized patients N Engl J Med 352 2005 969 977
26. M.R. Patel, T.J. Meine, J. Radeva State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction J Am Coll Cardiol 44 2004 192 198
27. B.S. Abella, J.P. Alvarado, H. Myklebust Quality of cardiopulmonary resuscitation during in-hospital cardiac arrest JAMA 293 2005 305 310
28. L. Wik, J. Kramer-Johansen, H. Myklebust Quality of cardiopulmonary resuscitation during out-of-hospital cardiac arrest JAMA 293 2005 299 304
29. A.M. Zafari, S.K. Zarter, V. Heggen A program encouraging early defibrillation results in improved in-hospital resuscitation efficacy J Am Coll Cardiol 44 2004 846 852
30. M.J. Koren, D.B. Hunninghake Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics the ALLIANCE study J Am Coll Cardiol 44 2004 1772 1779
31. P.M. Ho, F.A. Masoudi, E.D. Peterson Cardiology management improves secondary prevention measures among patients with coronary artery disease J Am Coll Cardiol 43 2004 1517 1523
32. A.D. Galbreath, R.A. Krasuski, B. Smith Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure Circulation 110 2004 3518 3526
33. C. Kimmelstiel, D. Levine, K. Perry Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network the SPAN-CHF trial Circulation 110 2004 1450 1455
34. T.M. Koelling, M.L. Johnson, R.J. Cody, K.D. Aaronson Discharge education improves clinical outcomes in patients with chronic heart failure Circulation 111 2005 179 185
35. E.H. Bradley, J. Herrin, Y. Wang Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction JAMA 292 2004 1563 1572
36. P.B. Bach, H.H. Pham, D. Schrag, R.C. Tate, J.L. Hargraves Primary care physicians who treat blacks and whites N Engl J Med 351 2004 575 584
37. A.E. Barnato, F.L. Lucas, D. Staiger, D.E. Wennberg, A. Chandra Hospital-level racial disparities in acute myocardial infarction treatment and outcomes Med Care 43 2005 308 319
38. S.H. Konety, M.S. Vaughan Sarrazin, G.E. Rosenthal Patient and hospital differences underlying racial variation in outcomes after coronary artery bypass graft surgery Circulation 111 2005 1210 1216
39. A. Voigt, R. Ezzeddine, W. Barrington Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001 J Am Coll Cardiol 44 2004 855 858
40. P.W. Groeneveld, P.A. Heidenreich, A.M. Garber Trends in implantable cardioverter-defibrillator racial disparity the importance of geography J Am Coll Cardiol 45 2005 72 78
41. N.E. Taylor, S. O'Brien, F.H. Edwards, E.D. Peterson, C.R. Bridges Relationship between race and mortality and morbidity after valve replacement surgery Circulation 111 2005 1305 1312
42. D. Satcher, G.E. Fryer Jr, J. McCann, A. Troutman, S.H. Woolf, G. Rust What if we were equal? A comparison of the black-white mortality gap in 1960 and 2000 Health Aff 24 2005 459 464
43. M. Huisman, A.E. Kunst, M. Bopp Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations Lancet 365 2005 493 500
44. J. Cromwell, N.T. McCall, J. Burton, C. Urato Race/ethnic disparities in utilization of lifesaving technologies by Medicare ischemic heart disease beneficiaries Med Care 43 2005 330 337
45. S.S. Rathore, H.M. Krumholz Differences, disparities, and biases clarifying racial variations in health care use Ann Intern Med 141 2004 635 638
46. D.M. Becker, L.R. Yanek, W.R. Johnson Jr Impact of a community-based multiple risk factor intervention on cardiovascular risk in black families with a history of premature coronary disease Circulation 111 2005 1298 1304
47. C. Smith, C. Cowan, A. Sensenig, A. Catlin Health spending growth slows in 2003 Health Aff 24 2005 185 194
48. T.A. Stukel, F.L. Lucas, D.E. Wennberg Long-term outcomes of regional variations in intensity of invasive vs medical management of Medicare patients with acute myocardial infarction JAMA 293 2005 1329 1337
49. W.S. Weintraub, Z. Zhang, E.M. Mahoney Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure Circulation 111 2005 1106 1113
50. W.S. Weintraub, E.M. Mahoney, A. Lamy Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation J Am Coll Cardiol 45 2005 838 845
51. P.A. Cowper, K. Udayakumar, M.H. Sketch Jr, E.D. Peterson Economic effects of prolonged clopidogrel therapy after percutaneous coronary intervention J Am Coll Cardiol 45 2005 369 376
52. D.J. Cohen, A.M. Lincoff, T.A. Lavelle Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention results from the REPLACE-2 trial J Am Coll Cardiol 44 2004 1792 1800
53. E. Bonnefoy, F. Lapostolle, A. Leizorovicz Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction study group Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction a randomised study Lancet 360 2002 825 829
54. J. Machecourt, E. Bonnefoy, G. Vanzetto Primary angioplasty is cost-minimizing compared with pre-hospital thrombolysis for patients within 60 min of a percutaneous coronary intervention center the Comparison of Angioplasty and Pre-hospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) cost-efficacy sub-study J Am Coll Cardiol 45 2005 515 524
55. A.L. Klein, R.A. Grimm, R.D. Murray Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation N Engl J Med 344 2001 1411 1420
56. A.L. Klein, R.D. Murray, E.R. Becker Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation the ACUTE economic data at eight weeks J Am Coll Cardiol 43 2004 1217 1224
57. D.S. Baim, D. Wahr, B. George Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts Circulation 105 2002 1285 1290
58. D.J. Cohen, S.A. Murphy, D.S. Baim Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts results from the SAFER trial J Am Coll Cardiol 44 2004 1801 1808
59. G.A. Lamas, K. Lee, M.O. Sweeney Ventricular pacing or dual-chamber pacing for sinus-node dysfunction N Engl J Med 346 2002 1854 1862
60. S. Rinfret, D.J. Cohen, G.A. Lamas Cost-effectiveness of dual-chamber pacing compared with ventricular pacing for sinus node dysfunction Circulation 111 2005 165 172
61. Bypass Angioplasty Revascularization Investigation (BARI) Investigators Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease N Engl J Med 335 1996 217 225
62. M.A. Hlatky, D.B. Boothroyd, K.A. Melsop Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease Circulation 110 2004 1960 1966
63. E.M. Antman, D.T. Anbe, P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) Circulation 110 2004 e82 e92
64. B.K. Nallamothu, E.M. Antman, E.R. Bates Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction does the choice of fibrinolytic agent impact on the importance of time-to-treatment? Am J Cardiol 94 2004 772 774
65. B.K. Nallamothu, E.R. Bates, J. Herrin, Y. Wang, E.H. Bradley, H.M. Krumholz Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States National Registry of Myocardial Infarction (NRMI)-3/4 analysis Circulation 111 2005 761 767
66. K.A.A. Fox, P.A. Poole-Wilson, R.A. Henderson Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction the British Heart Foundation RITA 3 randomised trial Lancet 360 2002 743 751
67. J. Kim, R.A. Henderson, S.J. Pocock, T. Clayton, M.J. Sculpher, K.A. Fox Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction one-year results of the third Randomized Intervention Trial of unstable Angina (RITA-3) J Am Coll Cardiol 45 2005 221 228
68. J.A. Spertus, A.C. Salisbury, P.G. Jones, D.G. Conaway, R.C. Thompson Predictors of quality-of-life benefit after percutaneous coronary intervention Circulation 110 2004 3789 3794
69. C.S. Fox, J.C. Evans, M.G. Larson, W.B. Kannel, D. Levy Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999 the Framingham Heart study Circulation 110 2004 522 527
70. J. Critchley, J. Liu, D. Zhao, W. Wei, S. Capewell Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999 Circulation 110 2004 1236 1244
71. S.D. de Ferranti, K. Gauvreau, D.S. Ludwig, E.J. Neufeld, J.W. Newburger, N. Rifai Prevalence of the metabolic syndrome in American adolescents findings from the third National Health and Nutrition Examination Survey Circulation 110 2004 2494 2497
72. E.S. Ford, W.H. Giles, A.H. Mokdad The distribution of 10-year risk for coronary heart disease among U.S. adults findings from the National Health and Nutrition Examination Survey III J Am Coll Cardiol 43 2004 1791 1796
73. A.A. Hedley, C.L. Ogden, C.L. Johnson, M.D. Carroll, L.R. Curtin, K.M. Flegal Prevalence of overweight and obesity among U.S children, adolescents, and adults, 1999-2002 JAMA 291 2004 2847 2850
74. V.L. Roger, S.A. Weston, M.M. Redfield Trends in heart failure incidence and survival in a community-based population JAMA 292 2004 344 350
75. T.M. Koelling, R.S. Chen, R.N. Lubwama, G.J. L'Italien, K.A. Eagle The expanding national burden of heart failure in the United States the influence of heart failure in women Am Heart J 147 2004 74 78
76. M.L. Daviglus, K. Liu, L.L. Yan Relation of body mass index in young adulthood and middle age to Medicare expenditures in older age JAMA 292 2004 2743 2749
77. M.L. Dansinger, J.A. Gleason, J.L. Griffith, H.P. Selker, E.J. Schaefer Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction a randomized trial JAMA 293 2005 43 53
78. K.T. Knoops, L.C. de Groot, D. Kromhout Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women the HALE project JAMA 292 2004 1433 1439
79. S. Yusuf, S. Hawken, S. Ounpuu Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study) case-control study Lancet 364 2004 937 952